申请人:Gelder M. Van Joel
公开号:US20080039456A1
公开(公告)日:2008-02-14
Disclosed are novel rigidified compounds having a rhodanine-like residue and at least one aryl or heteroaryl residue linked to the rhodanine-like residue, whereby a core structure of these compounds, as defined in the specification, is characterized as having one or zero free-to-rotate bonds. Also disclosed are pharmaceutical compositions containing these rigidified compounds and uses thereof for modulating the activity of heparanase and hence in the treatment of heparanase-associated diseases and disorders, and uses thereof for modulating the activity of heparin-binding proteins and hence in the treatment of heparin-binding proteins-associated diseases and disorders as well as in the treatment of medical conditions that are at least partially treatable by rhodanine or a rhodanine analog.
揭示了一种新颖的刚性化合物,其具有类似罗丹啉的残基和至少一个连接到类似罗丹啉残基的芳基或杂芳基残基,其中这些化合物的核心结构,如规范中定义的那样,其特征是具有一个或零个可自由旋转的键。还披露了含有这些刚性化合物的药物组合物以及用于调节肝素酶活性的用途,从而治疗与肝素酶相关的疾病和紊乱,并用于调节肝素结合蛋白的活性以及治疗与肝素结合蛋白相关的疾病和紊乱,以及治疗至少部分可通过罗丹啉或罗丹啉类似物治疗的医疗状况的用途。